Literature DB >> 422190

Paragangliomas of the head and neck region. A pathologic study of tumors from 71 patients.

E E Lack, A L Cubilla, J M Woodruff.   

Abstract

The histopathology of 72 paragangliomas originating in the head and neck region of 71 patients is presented. There were 45 carotid body, 13 vagal body, eight jugulotympanic, and three nasal paragangliomas. In addition, two arose in the larynx and one in the area of the aortic arch. Tumors occurred in four unrelated families. The two most important histologic features leading to a diagnosis of paraganglioma were zellballen and the presence of cytoplasmic argyrophil granules in all cases in which staining with the Grimelius technique was carried out. Ultrastructural study of three carotid body and two vagal body paragangliomas revealed both light and dark chief cells. Tumor cells contained membrane bound, electron dense neurosecretory types of granules, which usually ranged in diameter from 120 to 200 nm. Follow-up information was available for 67 patients (94 per cent). Two of the three nasal paragangliomas, 50 per cent of the jugulotympanic paragangliomas, 17 per cent of the vagal body paragangliomas, and 10 per cent of those of the carotid body recurred locally following attempted surgical resection. All patients treated with radiation had persistent tumor. Four (9 per cent) of the carotid body paragangliomas were malignant, all four patients dying with widespread metastases. One vagal body paragangliomas metastasized to regional lymph nodes (the patient was alive and well at five years), and another caused death by direct intracranial extension. In contrast to the benign tumors, malignant paragangliomas tended to show foci of necrosis and vascular invasion. Mitotic figures, which usually were not identified in the benign cases, were seen in all malignant tumors.

Entities:  

Mesh:

Year:  1979        PMID: 422190     DOI: 10.1016/s0046-8177(79)80008-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  45 in total

1.  Studies for estimating the biologic behavior and prognosis of paragangliomas in the head and neck.

Authors:  H J Welkoborsky; Y Xiao; W J Mann; R G Amedee; H P Dienes; B Volk
Journal:  Skull Base Surg       Date:  1995

2.  Prognostic Factors Including Proliferation Markers Ki-67, bax, and bcl-2 in Temporal Bone Paraganglioma.

Authors:  M Gjuric; U Völker; A Katalinic; S R Wolf
Journal:  Skull Base Surg       Date:  1997

3.  Peptide receptor radionuclide therapy with (90)Y/ (177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours).

Authors:  Ameya D Puranik; Harshad R Kulkarni; Aviral Singh; Richard P Baum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-31       Impact factor: 9.236

4.  Cervical paragangliomas: neurovascular surgical risk and therapeutic management.

Authors:  J Paris; F Facon; J M Thomassin; M Zanaret
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-06       Impact factor: 2.503

5.  Cervical paragangliomas-tumor control and long-term functional results after surgery.

Authors:  Malte Kollert; Amir A Minovi; Wolfgang Draf; Ulrike Bockmühl
Journal:  Skull Base       Date:  2006-11

6.  Familial cervical paragangliomas with lymph node metastasis expressing somatostatin receptor type 2A.

Authors:  Noriko Kimura; Hiroo Tateno; Shigeru Saijo; Akira Horii
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

Review 7.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 8.  Paraganglioma of the nasal cavity: a case report.

Authors:  Sheyda Ketabchi; Daniela Massi; Roberto Santoro; Alessandro Franchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-01-21       Impact factor: 2.503

Review 9.  [Dignity of carotid body tumors. Review of the literature and clinical experiences].

Authors:  D Grotemeyer; S M Loghmanieh; S Pourhassan; T A Sagban; F Iskandar; P Reinecke; W Sandmann
Journal:  Chirurg       Date:  2009-09       Impact factor: 0.955

10.  Mitochondrial and nuclear genes of mitochondrial components in cancer.

Authors:  E Kirches
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.